Literature DB >> 31983291

Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region.

Yasser Wali1,2, Vishwanatha Kini3, Mohamed A Yassin4.   

Abstract

Background/Objective: Stroke is a potentially fatal complication of sickle cell disease (SCD). Transcranial Doppler (TCD) is useful at identifying increased risk of stroke in children with SCD and vasospasm after subarachnoid hemorrhage. The main aim of this study was to determine the proportion of patients with SCD in the Gulf region who are at a high risk of stroke, as determined by TCD.
Methods: This multicenter (Oman, Qatar, and UAE), descriptive, cross-sectional study in patients (aged 2-16 years) with SCD included a baseline visit, 1 follow-up visit for patients with conditional TCD, and 3-year retrospective data analysis for all patients.
Results: Of the 410 eligible patients (Oman, 86.5%; Qatar, 8.2%; UAE, 5.1%), most had a TCD finding (left side, 91.7%; right side, 92.0%) of normal velocity (<155 cm/s) at baseline. For 6 of 7 patients with conditional velocity (155-179 cm/s) and 1 patient with high velocity (≥180 cm/s), baseline TCD results were not confirmed at follow-up. As per bivariate linear regression, age, race, transfusion type, and transfusion frequency were significant predictors of the TCD velocities. Multivariate logistic regressions revealed that TCD velocities were significantly correlated with sex, race, and type of transfusion. No patients reported any adverse events at follow-up. No deaths occurred during the study.Discussion/Conclusions: The study results show that far fewer patients with SCD in the Gulf have abnormal TCD findings than the internationally reported. Larger studies are needed to identify the factors underlying this observation.

Entities:  

Keywords:  Cerebro-vascular accident; Gulf region; multi-center; primary prevention; sickle cell disease; transcranial Doppler ultrasound; transfusion; vaso-occlusive crises

Year:  2020        PMID: 31983291     DOI: 10.1080/16078454.2020.1714113

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

1.  Analysis of Causes of Hospitalization Among Children with Sickle Cell Disease in a Group of Private Hospitals in Jeddah, Saudi Arabia.

Authors:  Shereen M Abd El-Ghany; Aisha T Tabbakh; Khulud I Nur; Rayan Y Abdelrahman; Sara M Etarji; Bayan Y Almuzaini
Journal:  J Blood Med       Date:  2021-08-11

2.  SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: A report of two cases.

Authors:  Elrazi Ali; Ahmed Hatim; Mohamed Yassin
Journal:  Clin Case Rep       Date:  2022-06-09

3.  Protocol for "Genetic composition of sickle cell disease in the Arab population: A systematic review".

Authors:  Fateen Ata; Zohaib Yousaf; Sundus Sardar; Saad Javed; Phool Iqbal; Ibraheem Khamees; Lujain Salahaldeen Malkawi; Mohamed A Yassin
Journal:  Health Sci Rep       Date:  2022-05-03

4.  Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease.

Authors:  Awni Alshurafa; Mohamed A Yassin
Journal:  Front Med (Lausanne)       Date:  2022-09-15

Review 5.  Manifestations of HbSE sickle cell disease: a systematic review.

Authors:  Ibrahim Khamees; Fateen Ata; Hassan Choudry; Ashraf T Soliman; Vincenzo De Sanctis; Mohamed A Yassin
Journal:  J Transl Med       Date:  2021-06-16       Impact factor: 5.531

6.  Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report.

Authors:  Waail Rozi; Elrazi Awadelkarim Hamid Ali; Abdulrahman F Al-Mashdali; Mohamed Abdelrazek; Mohamed A Yassin
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.